Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MTNB | ZTS | TAK | UTHR | NBIX |
| Company | Matinas Biopharma Hl | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.6400 | 162.24 | 13.25 | 360.92 | 138.32 |
| High | 0.6850 | 163.87 | 13.27 | 364.19 | 139.52 |
| Low | 0.6020 | 160.59 | 13.20 | 355.86 | 137.17 |
| Last | 0.6350 | 163.31 | 13.26 | 356.33 | 138.10 |
| Change | +0.0470 | +0.70 | +0.01 | -3.89 | +0.24 |
| % Change | +7.99% | +0.43% | +0.08% | -1.08% | +0.17% |
| Volume | 206,300 | 2,206,300 | 1,050,200 | 235,300 | 745,400 |
| 20-Day Average Volume | 104,810 | 2,338,665 | 1,486,720 | 302,710 | 972,655 |
| Previous Close | 0.5880 | 162.61 | 13.25 | 360.22 | 137.86 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5629 | 169.62 | 13.33 | 363.21 | 133.57 |
| 20-Day Raw Stochastic | 75.85% | 12.79% | 32.56% | 17.69% | 86.80% |
| 20-Day Relative Strength | 36.47% | 35.17% | 43.94% | 45.22% | 63.75% |
| Weighted Alpha | -74.55 | -16.70 | -9.89 | +50.07 | +5.64 |
| Today's Opinion | 88% Sell | 88% Sell | 88% Sell | 24% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 88% Sell | 24% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 8% Sell | 80% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.95% since 12/26/24 | -1.34% since 12/26/24 | +0.91% since 12/26/24 | -2.13% since 12/26/24 | -0.67% since 12/26/24 |
| Low | 0.4780 on 12/30/24 | 160.59 on 01/03/25 | 13.12 on 12/31/24 | 350.93 on 01/02/25 | 136.01 on 12/31/24 |
| High | 0.6850 on 01/03/25 | 166.53 on 12/27/24 | 13.32 on 12/27/24 | 364.60 on 12/27/24 | 139.82 on 12/27/24 |
| 1-Month | |||||
| %Chg | +14.95% since 12/03/24 | -7.70% since 12/03/24 | -4.74% since 12/03/24 | -3.38% since 12/03/24 | +10.09% since 12/03/24 |
| Low | 0.4780 on 12/30/24 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 350.60 on 12/19/24 | 125.21 on 12/04/24 |
| High | 0.6850 on 01/03/25 | 181.85 on 12/13/24 | 13.84 on 12/09/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 3-Month | |||||
| %Chg | -78.47% since 10/03/24 | -14.49% since 10/03/24 | -6.88% since 10/03/24 | +1.79% since 10/03/24 | +23.44% since 10/03/24 |
| Low | 0.4780 on 12/30/24 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 342.02 on 10/23/24 | 110.99 on 10/08/24 |
| High | 4.2500 on 10/18/24 | 196.55 on 10/17/24 | 14.48 on 10/04/24 | 417.82 on 11/08/24 | 140.00 on 12/18/24 |
| 6-Month | |||||
| %Chg | -92.07% since 07/03/24 | -7.00% since 07/03/24 | +1.14% since 07/03/24 | +14.56% since 07/03/24 | -0.09% since 07/03/24 |
| Low | 0.4780 on 12/30/24 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 310.00 on 07/31/24 | 110.95 on 10/03/24 |
| High | 9.6000 on 07/16/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,230 | 73,679,752 | 42,191,664 | 15,908,352 | 13,982,211 |
| Shares Outstanding, K | 5,087 | 451,165 | 3,181,875 | 44,645 | 101,247 |
| Annual Sales | 1,100,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -22,940,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 0 | 2,388,000,000 | 7,903,930,000 | 748,900,000 | 622,100,000 |
| Last Quarter Net Income | -4,280,000 | 682,000,000 | 618,620,000 | 309,100,000 | 129,800,000 |
| 60-Month Beta | 1.61 | 0.89 | 0.51 | 0.57 | 0.33 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 11/13/24 | 1.58 on 11/04/24 | 0.44 on 10/31/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 |
| Latest Earnings Date | 11/13/24 | 02/11/25 | 02/06/25 | 02/19/25 | 02/05/25 |
| Most Recent Dividend | N/A | 0.432 on 10/31/24 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.23 | 8.77 | 15.82 | 36.96 |